Barclays PLC Rvl Pharmaceuticals PLC Transaction History

Barclays PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$1.02 - $1.39 $9,812 - $13,371	-9,620 Reduced 41.26%	13,697 $16,000
Q4 2022 Feb 13, 2023	BUY	$1.02 - $1.61 $20,877 - $32,953	20,468 Added 718.43%	23,317 $26,000
Q3 2022 Nov 03, 2022	BUY	$1.28 - $2.91 $3,646 - $8,290	2,849 New	2,849 $6,000
Q4 2021 Feb 14, 2022	SELL	$0.98 - $3.06 $2,376 - $7,420	-2,425 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.79 - $4.19 $7,488 - $11,245	-2,684 Reduced 52.53%	2,425 $7,000
Q2 2021 Aug 13, 2021	SELL	$2.8 - $3.78 $16,309 - $22,018	-5,825 Reduced 53.27%	5,109 $15,000
Q1 2021 May 13, 2021	BUY	$3.26 - $4.84 $21,238 - $31,532	6,515 Added 147.43%	10,934 $36,000
Q4 2020 Feb 11, 2021	SELL	$4.12 - $6.29 $6,575 - $10,038	-1,596 Reduced 26.53%	4,419 $17,000
Q3 2020 Nov 12, 2020	SELL	$4.82 - $8.77 $3,287 - $5,981	-682 Reduced 10.18%	6,015 $32,000
Q2 2020 Aug 12, 2020	BUY	$2.83 - $6.99 $10,620 - $26,233	3,753 Added 127.48%	6,697 $46,000
Q1 2020 May 13, 2020	SELL	$3.18 - $7.0 $16,796 - $36,974	-5,282 Reduced 64.21%	2,944 $9,000
Q4 2019 Feb 10, 2020	BUY	$3.46 - $7.7 $14,442 - $32,139	4,174 Added 103.01%	8,226 $57,000
Q3 2019 Nov 14, 2019	SELL	$2.8 - $3.99 $12,644 - $18,018	-4,516 Reduced 52.71%	4,052 $15,000
Q2 2019 Aug 14, 2019	BUY	$2.34 - $4.28 $13,595 - $24,866	5,810 Added 210.66%	8,568 $33,000
Q1 2019 May 15, 2019	BUY	$3.6 - $8.75 $9,928 - $24,132	2,758 New	2,758 $10,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.